Lataa...
Targeting PI3K in Cancer: Any Good News?
The phosphatidylinositol 3-kinase (PI3K) signaling pathway regulates several cellular processes and it’s one of the most frequently deregulated pathway in human tumors. Given its prominent role in cancer, there is great interest in the development of inhibitors able to target several members of PI3K...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3647219/ https://ncbi.nlm.nih.gov/pubmed/23658859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00108 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|